LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces…
Continue ReadingEtiqueta: Business Wire
Best Logo Design Contest Platforms (2024): Top Logo Design Sites Ranked by Compare Before Buying
BOSTON–(BUSINESS WIRE)–Compare Before Buying has published a comprehensive review of the best logo design contest platforms…
Continue Reading
Travel + Leisure Co. Highlights Ongoing Commitment to Responsible Global Tourism with Release of New ESG Report
ORLANDO, Fla.–(BUSINESS WIRE)–Travel + Leisure Co. (NYSE:TNL), the world’s leading membership and leisure travel company, today…
Continue Reading
Arcosa, Inc. Announces Closing of $600 Million of 6.875% Senior Notes Due 2032
DALLAS–(BUSINESS WIRE)–Arcosa, Inc. (NYSE: ACA) (“Arcosa”) today announced it has closed the previously announced private offering…
Continue Reading
Botanical Solution Inc. (BSI) Series A Extended to Over $23 Million
Funding to accelerate scalable commercial production of pharmaceutical grade QS-21 for human vaccines, R&D lab expansion,…
Continue ReadingHovde Group Expands Depository Team With Addition of Veteran Investment Banker James F. Hemmer
CHICAGO–(BUSINESS WIRE)–Hovde Group, LLC (“Hovde”), a leading full-service investment bank and broker dealer that provides investment…
Continue Reading
KB Home Announces the Grand Opening of Its Newest Community Within the Desirable Crossroads West Master Plan in Riverbank, California
Enclave at Crossroads West offers personalized, spacious, new homes and family friendly amenities close to local…
Continue Reading
Omeros Corporation to Announce Second Quarter Financial Results on August 7, 2024
SEATTLE–(BUSINESS WIRE)–Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its financial results for…
Continue Reading
Triple-I Offers Floridians, Southeast U.S. Residents Preparedness Tips for Impacts of Tropical Storm Debby
ST. JOHNS, Fla.–(BUSINESS WIRE)–Residents of Florida and the Southeast should be alert for the potential impacts…
Continue Reading
RIBOMIC Announces Completion of Patient Enrollment in Early Phase II Study of umedaptanib pegol for Achondroplasia and Initiation of Dosing in Cohort 2 of Early Phase II Clinical Study
TOKYO–(BUSINESS WIRE)–RIBOMIC Inc. (TOKYO:4591), a clinical-stage pharmaceutical company specializing in aptamer therapeutics, today announced that 13…
Continue Reading